Gaush Meditech Ltd announced that its board of directors will convene on 28 August 2026 to review and approve the Group’s interim financial results for the six months ended 30 June 2026. The agenda also includes deliberation on the declaration of an interim dividend, if any.

The notice, dated 18 August 2026, confirms that Chairman and Executive Director Mr. Gao Tieta will preside over the meeting. The current board comprises five executive directors (Mr. Gao Tieta, Mr. Liu Xinwei, Mr. Zhao Xinli, Mr. Zhang Jianjun and Ms. Li Wenqi), one non-executive director (Dr. David Guowei Wang) and three independent non-executive directors (Ms. Cheng Juan, Mr. Yubing Li and Ms. Qiu Xiaoling).

The scheduled meeting will determine the timing and amount of any interim dividend, subject to board approval, and will facilitate the timely publication of the company’s interim results.